patent 3 페이지

본문 바로가기
Home  >  Technology  >  Patents and Publications
  • Kwon HC, Cheong JY, Cho SW, Choi JM, Hong SP, Kim SO, Yoo WD. Emergence of adefovir-resistant mutants after reversion to YMDD wild-type in lamivudine-resistant patients receiving adefovir monotherapy. J Gastroenterol Hepatol. 2009 ;24:49-54.

  • Cha CK, Kwon HC, Cheong JY, Cho SW, Hong SP, Kim SO, Yoo WD. Association of Lamivudine-Resistant Mutational Patterns with Antiviral Effect of Adefovir in Patients with Chronic Hepatitis B. J Med Virol 2009; 81(3):417-424.

  • Hong SP, Shin SG, Lee EH, Chung HJ, Park SN, Yoo WD, Folk WR, Kim SO. High-resolution virus genotyping by MALDI-TOF mass spectrometry. Nature Protocols 2008; 3(9):1476-1484

  • Hong SP, Chung HJ, Lee HS, Lee SH, Lee SD, Oh HB, Kim WK, Song JH, Yoo WD, Folk WR, Kim SO. A Simple and Accurate Genotyping Strategy Based on TypeIIS Restriction Endonuclease Cleavage and Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry. BMC

  • Kwon CI, Hwang SG, Shin SJ, Chang SW, Kim SY, Ko KH, Hong SP, Park PW, Rim KS, Kang MS, Chung HJ, Hong SP. Occult hepatitis B virus infection in pregnant woman and its clinical implication. Liver Int. 2008;28(5):667-674.

  • Cheong JY, Cho SW, Yoo JH, Hong SP, Kim SO, Yoo WD, Kim JH. Selection of Precore Mutants during Lamivudine Treatment in Patients with Chronic Hepatitis B. Hepato-gastroenterology 2008:55;1029-1033.

  • Lee EH, Lee KB, Kim EO, Shin SK, Lee HS, Shim SY, Kim SO, Hong SP. Clinical Effectiveness of Restriction Fragment Mass Polymorphism assay for human papillomavirus genotyping. J Lab Med Qual Assur 2008 ;30(2):291-9.

  • Kim SO, Oh HB, Jun KR, Hwang SH, Cha CH, Kim KM, Folk WR, Hong SP, Suh DJ. Hepatitis C Virus Genotype 6 Variant Identified in Korea by analysis of 5' Untranslated Region Using a Matrix Assisted Laser Desorption/Ionization Time of flight -based Assay, Res

  • Cho JH, Cheong JY, Kang JK, Park JS, Lee MH, Lim NK, Hong SP, Kim SO, Yoo WD, Cho SW. Factors affecting initial virologic response and emergence of resistant mutants after adefovir treatment in lamivudine-resistant chronic hepatitis B patients. Korean J H

  • Lee HW, Lee JI, Um SH, Ahn SH, Chang HY, Park YK, Hong SP, Moon YM, Han KH. Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study. J Gastroenterol Hepatol. 2008;(5)

  • Hwang SH, Oh HB, Choi SE, Hong SP, Yoo W. Effective Screening of Informative Single Nucleotide Polymorphisms using the Novel Method of Restriction Fragment Mass Polymorphism. Journal of International Medical Research 2007;35: 827-835.

  • Kim OJ*, Hong SP*, Ahn JY, Hong SH, Hwang TS, Kim SO, Yoo W, Oh DH, Kim NK. Influence of Combined Methionine Synthase (MTR 2756A>G) and Methylenetetrahydrofolate Reductase (MTHFR 677C>T) Polymorphisms to Plasma Homocysteine Levels in Korean Patients with

  • Yim HJ, Myun KS, Chang YJ, Suh YS, Yeon JE, Lee CH. Kwon JA, Yoo W, Kim SO, Hong SP. The Levels of Hepatitis B Virus Replication during Non-replicative Phase - HBV Quantification by Real Time PCR in Korea. Digestive Diseases and Science. 2007;52:2403-2409

  • Sohn SK, Moon JH, Cho YY, Chae YS, Kim JG, Lee KS, Hong SP, Kim SO. Efficacy of dose escalation of imatinib mesylate in patients with cytogenetic or hematologic resistance. Leuk Lymphoma 2007;48(98):1659-1661.

  • Lee EH, Chung HJ, Oh HB, Chi HS, Jee MS, Park SN, Hong SP, Yoo W, Kim SO. Human Papilloma Virus Genotyping Assay using Restriction Fragment Mass Polymorphism Analysis, and Its Comparison with Sequencing and Hybrid Capture Assays. Korean J Lab Med 2007;27:

  • Chung HJ, Kim SN, Lee EH, Jee MS, Kim MA, Hwang SY, Cho HJ, Kim SO, Hong SP. Comparison of Efficacy of Human Papilloma Virus Genotyping Assays using Restriction Fragment Mass Polymorphism and DNA Chip Analysis in Patients with Abnormal Pap Smear and Uteri

  • Lee YS, Suh DJ, Lim YS, Jung SW, Kim KM, Lee HJ, Chung YH, Lee YS, Yoo WD, Kim SO. Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy. Hepatology 2006;43:1385-13

  • Ahn SH, Kim DY, Chang HY, Hong SP, Shin JS, Kim YS, Kim H, Paik YH, Lee KS, Chon CY, Moon YM, Han KH. Association of Genetic Variations in CCR5 and Its Ligand, RANTES with Clearance of Hepatitis B Virus in Korea. Journal of Medial Virology. 2006;78(12):15

  • Paik YH, Han KH, Hong SP, Lee HW, Lee KS, Kim SO, Shin JE, Ahn SH, Chon CY, Moon YM. Clinical impact of early detection for YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B. Antiviral Therapy. 2006. 11:447-4

  • Yeon JE, Yoo W, Hong SP, Chang YJ, Yu SK, Kim JH, Seo YS, Chung HJ, Moon MS, Kim SO, Byun KS, Lee CH. Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil. Gut 2006. 55(10):1488-95.